Bentz, Joe <br/><br/>
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Jul 2013 
 - 1347-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.112.050500  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--antagonists & inhibitors<br/>Animals<br/>Biological Transport<br/>Caco-2 Cells<br/>Digoxin--pharmacokinetics<br/>Dogs<br/>Drug Interactions<br/>Humans<br/>Inhibitory Concentration 50<br/>LLC-PK1 Cells<br/>Principal Component Analysis<br/>Risk Assessment<br/>Swine